1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Coenzyme Q10 (CoQ10) Market Analysis By Application (Dietary Supplements, Pharmaceuticals, Cosmetics) And Segment Forecasts To 2020

The global CoQ10 market is expected to reach USD 849.5 million by 2020. Growth of personal care industry particularly in BRIC nations is expected to remain a key driving factor for the global CoQ10 market. Increasing penetration of CoQ10 in medical industry is also expected to have positive influence on market growth. Constantly fluctuating CoQ10 prices is expected to remain a key challenge for market participants over the forecast period.

Dietary supplements emerged as the leading application for CoQ10 and accounted for 59.9% of total market volume in 2013. Increasing health concerns is expected to drive the demand for antioxidants and energy supplements which in turn is expected to drive CoQ10 demand over the next six years. Pharmaceutical is expected to be the most lucrative application segment and is expected to grow at an estimated CAGR of 9.9% from 2014 to 2020. Cardiac benefits of CoQ10 coupled with increasing prevalence of cardiovascular diseases across the globe are major factors driving its demand in pharmaceutical applications.

Further key findings from the study suggest:

Global CoQ10 market demand was 624.8 kilo tons in 2013 and is expected to reach 1,168 kilo tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020.
North America was the largest regional market for CoQ10 and accounted for over half of total market volume in 2013. Increasing application of CoQ10 in cosmetics such as anti-ageing and sunscreen lotions particularly in the U.S. is expected to drive the regional market. Non recognition of CoQ10 in pharmaceuticals by U.S. FDA is expected to remain a key challenge for the regional market.
Asia Pacific is expected to witness highest growth rate over the next six years. The region is expected to grow at an estimated CAGR of 10.1% from 2014 to 2020. Growth of major end-use industries such as pharmaceuticals and cosmetics particularly in emerging markets of China and India is expected to drive the regional CoQ10 market. Increasing health awareness is also expected to have a positive influence on regional CoQ10 demand.
The global CoQ10 market witnessed drop in prices from 2009 to 2014 on account of emergence of large number of local manufacturers in China. The prices are expected to increase over the forecast period owing to the exit of Mitsubishi Gas Chemical Co. from the market which has substantially limited supply.
Some of the major companies operating the global market include ZMC-USA, Kaneka Corporation, Gnosis S.p.A., DSM Nutritional Products, PharmaEssentiA Corporation and Xiamen Kingdomway Co.
For the purpose of this study, Grand View Research has segmented the CoQ10 market on the basis of application and region:

Global CoQ10 Application Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2020)
- Dietary Supplements
- Pharmaceuticals
- Cosmetics
- Others
Global CoQ10 Regional Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2020)
- North America
- Europe
- Asia Pacific
- RoW

Table Of Contents

Coenzyme Q10 (CoQ10) Market Analysis By Application (Dietary Supplements, Pharmaceuticals, Cosmetics) And Segment Forecasts To 2020
Chapter 1 Executive Summary
1.1 CoQ10 - Industry Summary and Critical Success Factors (CSFs)
Chapter 2 CoQ10 Industry Outlook
2.1 Market Segmentation
2.2 Market Size and Growth Prospects
2.3 CoQ10 Value Chain Analysis
2.4 CoQ10 Market Dynamics
2.4.1 Market driver analysis
2.4.2 Market restraint analysis
2.5 Key Opportunities Prioritized
2.6 Industry Analysis - Porter's
2.7 CoQ10 - Company Market Share Analysis
2.8 CoQ10 - PESTEL Analysis
Chapter 3 CoQ10 Application Outlook
3.1 Dietary Supplements
3.1.1 CoQ10 demand from dietary supplements, 2012-2020, (USD Million)
3.2 Pharmaceuticals
3.2.1 CoQ10 demand from pharmaceuticals, 2012-2020, (USD Million)
3.3 Cosmetics
3.3.1 CoQ10 demand from cosmetics, 2012-2020, (USD Million)
3.4 Other
3.4.1 CoQ10 demand from other applications, 2012-2020, (USD Million)
Chapter 4 CoQ10 Regional Outlook
4.1 North America
4.1.1 CoQ10 market by application, 2012-2020, (USD Million)
4.2 Europe
4.2.1 CoQ10 market by application, 2012-2020, (USD Million)
4.3 Asia Pacific
4.3.1 CoQ10 market by application, 2012-2020, (USD Million)
4.4 RoW
4.4.1 CoQ10 market by application, 2012-2020, (USD Million)
Chapter 5 Competitive landscape
5.1 Kaneka Corporation
5.1.1 Company Overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 Mitsubishi Gas Chemical Co.
5.2.1 Company Overview
5.2.2 Financial Performance
5.2.3 Product Benchmarking
5.2.4 Strategic Initiatives
5.3 Gnosis S.p.A.
5.3.1 Company Overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.3.4 Strategic Initiatives
5.4 Hwail Pharmaceutical Co. Ltd.
5.4.1 Company Overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.4.4 Strategic Initiatives
5.5 Kyowa Hakko U.S.A. Inc.
5.5.1 Company Overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 DSM Nutritional Products
5.6.1 Company Overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 PharmaEssentia Corporation
5.7.1 Company Overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.7.4 Strategic Initiatives
5.8 ZMC-USA LLC
5.8.1 Company Overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic Initiatives
5.9 Nisshin Seifun Group Inc.
5.9.1 Company Overview
5.9.2 Financial Performance
5.9.3 Product Benchmarking
5.9.4 Strategic Initiatives
Chapter 6 Methodology and Scope
6.1 Research Methodology
6.2 Research Scope and Assumptions
6.3 List of Data Sources


List of Tables

1. CoQ10 - Industry Summary and Critical Success Factors (CSFs)
2. CoQ10 market revenue, 2012 - 2020
3. CoQ10 - Key driver analysis
4. CoQ10 - Key restraint analysis
5. CoQ10 demand from dietary supplements, revenue, 2012 - 2020, (USD Million)
6. CoQ10 demand from dietary supplements, revenue, by region, 2012-2020 (USD Million)
7. CoQ10 demand from pharmaceuticals, revenue, 2012 - 2020, (USD Million)
8. CoQ10 demand from pharmaceuticals, revenue, by region, 2012-2020, (USD Million)
9. CoQ10 demand from cosmetics, revenue, 2012 - 2020, (USD Million)
10. CoQ10 demand from cosmetics, revenue, by region, 2012-2020, (USD Million)
11. CoQ10 demand from other applications, revenue, 2012-2020, (USD Million)
12. CoQ10 demand from other applications, revenue, by region, 2012-2020, (USD Million)
13. North America CoQ10 market revenue, 2012 - 2020, (USD Million)
14. North America CoQ10 market revenue, by application, (USD Million), 2012 - 2020
15. Europe CoQ10 market revenue, 2012 - 2020, (USD Million)
16. Europe CoQ10 market revenue, by application, (USD Million), 2012 - 2020
17. Asia Pacific CoQ10 market revenue, 2012 - 2020, (USD Million)
18. Asia Pacific CoQ10 market revenue, by application, (USD Million), 2012 - 2020
19. RoW CoQ10 market revenue, 2012 - 2020, (USD Million)
20. RoW CoQ10 market revenue, by application, (USD Million), 2012 - 2020


List of Figures

1. CoQ10 market segmentation
2. Global CoQ10 market (Revenue), 2012 - 2020
3. CoQ10 - Value chain analysis
4. CoQ10 - Market dynamics
5. CoQ10 - Company market share analysis, 2013
6. Key opportunities prioritized
7. CoQ10 - Porter's analysis
8. CoQ10 - Company market share analysis, 2013
9. CoQ10 - SWOT Analysis
10. CoQ10 market share by application, 2013 and 2020
11. CoQ10 demand from dietary supplements, revenue, 2012 - 2020, (USD Million)
12. CoQ10 demand from pharmaceuticals, revenue, 2012 - 2020, (USD Million)
13. CoQ10 demand from cosmetics, revenue, 2012 - 2020, (USD Million)
14. CoQ10 demand from other applications, revenue, 2012-2020, (USD Million)
15. CoQ10 market share by region, 2013 and 2020
16. North America CoQ10 market revenue by application, 2012 - 2020, (USD Million)
17. Europe CoQ10 market revenue by application, 2012 - 2020, (USD Million)
18. Asia Pacific CoQ10 market revenue by application, 2012 - 2020, (USD Million)
19. RoW CoQ10 market revenue by application, 2012 - 2020, (USD Million)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.